155 related articles for article (PubMed ID: 11872642)
1. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens.
Belinsky SA; Snow SS; Nikula KJ; Finch GL; Tellez CS; Palmisano WA
Carcinogenesis; 2002 Feb; 23(2):335-9. PubMed ID: 11872642
[TBL] [Abstract][Full Text] [Related]
2. Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
Swafford DS; Middleton SK; Palmisano WA; Nikula KJ; Tesfaigzi J; Baylin SB; Herman JG; Belinsky SA
Mol Cell Biol; 1997 Mar; 17(3):1366-74. PubMed ID: 9032263
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.
Nguyen TT; Nguyen CT; Gonzales FA; Nichols PW; Yu MC; Jones PA
Prostate; 2000 May; 43(3):233-42. PubMed ID: 10797499
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
[TBL] [Abstract][Full Text] [Related]
7. Distinct susceptibility of induction of methylation of p16ink4a and p19arf CpG islands by X-radiation and chemical carcinogen in mice.
Yang C; Gu L; Deng D
Mutat Res Genet Toxicol Environ Mutagen; 2014 Jul; 768():42-50. PubMed ID: 24780116
[TBL] [Abstract][Full Text] [Related]
8. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines.
Honoki K; Tsujiuchi T; Mori T; Yoshitani K; Tsutsumi M; Takakura Y; Mii Y
Mol Carcinog; 2004 Jan; 39(1):10-4. PubMed ID: 14694443
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
12. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.
Belinsky SA
Exp Lung Res; 1998; 24(4):463-79. PubMed ID: 9659578
[TBL] [Abstract][Full Text] [Related]
13. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in DNA methylation during multistep rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine.
Liu WB; Liu JY; Ao L; Zhou ZY; Zhou YH; Cui ZH; Yang H; Cao J
Toxicol Lett; 2009 Aug; 189(1):5-13. PubMed ID: 19409458
[TBL] [Abstract][Full Text] [Related]
16. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL
Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724
[TBL] [Abstract][Full Text] [Related]
17. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine.
Kato A; Shimizu K; Shimoichi Y; Fujii H; Honoki K; Tsujiuchi T
Mol Carcinog; 2006 Feb; 45(2):106-11. PubMed ID: 16329148
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
